European CLL Association – ECLLA is proud to work alongside Prof Oliver Karanfilski, Professor of Hematology and Internal Medicine and Consultant Hematologist from Macedonia, whose expertise brings an essential perspective to our Medical Advisory Board.
At the ECLLA Policy Roundtable in Dublin, Prof Karanfilski shared an inspiring perspective on the future of CLL treatment and the remarkable progress being made in the field.
With advances in targeted therapies and research continuing at an unprecedented pace, there is growing optimism that CLL may one day become a curable disease. However, achieving this vision requires ensuring that innovative treatments are accessible to all patients, not only those living in countries with the greatest resources.
Prof Karanfilski’s commitment to advancing knowledge, improving access, and advocating for “health for all” reflects the values that drive ECLLA’s work across Europe.
Thank you, Oliver, for your expertise, passion, and dedication to improving the future of CLL care.
👇 Watch European Policy Roundtable 2026 Reflections: Prof Oliver Karanfilski
#ECLLA #CLL #OneEuropeEqualCare